Pneumonia due to Pseudomonas aeruginosa;Neumonía por Pseudomonas aeruginosa

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue SUPPL.3, 2005, Pages 30-36

  Vallés, Jordi ^a,c   Mariscal, Dolors ^b  

^a PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^b UDIAT   (Spain)

^c HOSPITAL DE SABADELL   (Spain)

Author keywords

Nosocomial infection; Pneumonia; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; CLINICAL FEATURE; HUMAN; LUNG INFECTION; MONOTHERAPY; PATHOGENESIS; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; ARTIFICIAL VENTILATION; CLASSIFICATION; CROSS INFECTION; DISEASE TRANSMISSION; DRUG EFFECT; EQUIPMENT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; OROPHARYNX; PATHOGENICITY; REVIEW; VIRULENCE;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EQUIPMENT CONTAMINATION; HUMANS; OROPHARYNX; PNEUMONIA, BACTERIAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATION, ARTIFICIAL; RISK FACTORS; VIRULENCE;

EID: 33749065983     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13091218     Document Type: Article

References (40)

1. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. results of the european prevalence of infection in intensive care (EPIC) study. JAMA. 1995;274:639-44.
2. Bueno-Cavanillas A, Delgado-Rodríguez M, López-Luque A, Schaffino-Cano S, Gálvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med. 1994;22:55-60.
3. Stoutenbeeck ChP, Van Saene HKF. Prevention of pneumonia by selective decontamination of the digestive tract. Intensive Care Med. 1992;18:S18-S23.
4. Peacock SJ, Garrad CS. The challenge of Pseudomonas aeruginosa pneumonia. En: Vincent JL, editor. Yearbook of Intensive Care and Emergency Medicine. Berlín: Springer; 1997. p. 617-24.
5. Rello J, Quintana E, Ausina V, Castella J, Luquin M, Net A, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest. 1991;100:439-44.
6. Fagon JY, Chastre J, Domart Y, Trouilet JL, Pierre J, Darne C, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected speciemn brush and quantitative culture technique. Am Rev Respir Dis. 1989;139:877-84.
7. Torres A, Aznar R, Gatell JM, Jiménez P, González J, Ferrer A, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142:523-8.
8. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 1993;104:1230-5.
9. Vallés J, Mesalles E, Mariscal D, Del Mar Fernández M, Pena R, Jiménez JL, et al. A 7-year study of severe hospital-acquired pneumonia requering ICU admission. Intensive Care Med. 2003;29:981-8.
10. Coalson JJ. The pathology of nosocomial pneumonia. Clinics Chest Medicine. 1995;16:13-28.
11. Craven DE, Steger KA, Barat LM, Duncan RA. Nosocomial pneumonia: epidemiology and infection control. Intensive Care Med. 1992;18:S3-S9.
12. Tobin MJ, Grenvik A. Nosocomial lung infection and its diagnosis. Crit Care Med. 1984;12:191-9.
13. Bonten MJM, Bergmans DCJJ, Ambergen AW, De Leeuw PW, Van der Geest S, Stobberingh EE, et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med. 1996;154:1339-46.
14. Bergmans D, Bonten M. Colonization and infection with Pseudomonas aeruginosa in Intensive care: Endogenous or exogenous origin? En: Vincent JL, editor. Yearbook of Intensive Care and Emergency Medicine. Berlín: Springer; 1999. p. 131-40.
15. Bonten MJM, Gaillard CA, De Leeuw PW, Stobberingh EE. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 1997;24:309-19.
16. Bonten MJM, Gaillard CA, Van Tiel FH, Smeets HG, Van der Geest S, Stobberingh EE. The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients. Chest. 1994;105:878-84.
17. De Latorre FJ, Pont T, Ferrer A, Rossello J, Palomar M, Planas M. Pattern of tracheal colonization during mechanical ventilation. Am J Respir Crit Care Med. 1995;152:1028-33.
18. Niederman MS, Mantovani R, Schock P, Papas J, Fein AM. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients: the role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest. 1989;95:155-61.
19. Rello J, Ausina V, Ricart M, Pozo C, Quintana E, Net A, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med. 1994;20:193-8.
20. Vallés J, Mariscal D, Cortés P, Coll P, Villagra A, Díaz E, et al. Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia. Intensive Care Med. 2004;30:1768-75.
21. Reuter S, Sigge A, Wiedeck H, Trautmann M. Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets. Crit Care Med. 2002;30:2222-8.
22. Foca M, Jacob K, Whittier S, Della Latta P, Factor S, Rubenstein D, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med. 2000;343:695-700.
23. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005;171:1209-23.
24. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, et al. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest. 1999;104:743-50.
25. Hauser A, Cobb E, Bodí M, Mariscal D, Vallés J, Engel JN, et al. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med. 2002;30:521-8.
26. Smith RS, Harris SG, Phipps R, Iglewski B. The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol. 2002;184:1132-9.
27. Smith RS, Iglewski BH. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest. 2003;112:1460-5.
28. Lesprit P, Faurisson F, Joint-Lambert O, Roudot-Thoraval F, Foglino M, Vissuzaine C, et al. Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. Am J Respir Crit Care Med. 2003;167:1478-82.
29. Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;157:1165-72.
30. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997;156:1092-8.
31. Sutherland KR, Steinberg KP, Maunder RJ, Milberg JA, Allen DL, Hudson LD. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:550-6.
32. Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome. A prospective evaluation of bilateral bronchoscopic sampling. Am J Respir Crit Care Med. 1998;158:870-5.
33. Rello J, Ricart M. Infecciones del tracto respiratorio en pacientes intubados causadas por Pseudomonas aeruginosa. Rev Clin Española. 1998;198: 17-20.
34. Dunn M, Wunderink RG. Ventilator-associated pneumonia caused by Pseudomonas infection. Clinics Chest Medicine. 1995;16:95-109.
35. Rello J, Mariscal D, March F, Jubert P, Sánchez F, Vallés J et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med. 1998;157:912-6.
36. Rello J, Jubert P, Vallés J, Artigas A, Rue M, Niederman MS. Evaluation of outcome in intubated patients with pneumonia caused by Pseudomonas aeruginosa. Clin Infect Dis. 1996;23:973-8.
37. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-8.
38. Brewer SC, Wunderink RG, Jones CB, Leeper KV. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest. 1996;109:1019-29.
39. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540-6.
40. Fink MP, Snydman DR, Niederman MS, Leeper KV Jr., Johnson RH, Heard SO, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The severe pneumonia study group. Antimicrob Agents Chemother. 1994;38:547-57.